Found: 26
Select item for more details and to access through your institution.
Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. e352, doi. 10.1016/j.clgc.2021.05.005
- By:
- Publication type:
- Article
Current Management Strategy for Metastatic Renal Cell Carcinoma and Future Directions.
- Published in:
- Current Oncology Reports, 2017, v. 19, n. 4, p. 1, doi. 10.1007/s11912-017-0583-8
- By:
- Publication type:
- Article
Nivolumab-associated acute glomerulonephritis: a case report and literature review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Anti-angiogenesis in prostate cancer: knocked down but not out.
- Published in:
- Asian Journal of Andrology, 2014, v. 16, n. 3, p. 372, doi. 10.4103/1008-682X.125903
- By:
- Publication type:
- Article
Cabazitaxel: a new drug for metastatic prostate cancer.
- Published in:
- Asian Journal of Andrology, 2011, v. 13, n. 2, p. 185, doi. 10.1038/aja.2010.161
- By:
- Publication type:
- Article
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.00490
- By:
- Publication type:
- Article
Mechanisms of Immunotherapy Resistance in mCRPC: Identifying the Enemy on the Visceral Metastatic Battlefield.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Mechanisms of Immunotherapy Resistance in mCRPC: Identifying the Enemy on the Visceral Metastatic Battlefield.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 11, p. 986
- By:
- Publication type:
- Article
Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2014, v. 63, n. 3, p. 225, doi. 10.1007/s00262-013-1505-8
- By:
- Publication type:
- Article
Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 109, doi. 10.1007/s00262-011-1141-0
- By:
- Publication type:
- Article
Therapeutic Cancer Vaccines in Prostate Cancer: The Quest for Intermediate Markers of Response.
- Published in:
- Cancers, 2012, v. 4, n. 4, p. 1229, doi. 10.3390/cancers4041229
- By:
- Publication type:
- Article
QUETIAPINE IN MANAGEMENT OF MANIC SYMPTOMS IN PATIENT WITH HEART TRANSPLANTATION -- A CASE REPORT.
- Published in:
- Psychiatria Danubina, 2012, v. 24, n. 4, p. 402
- By:
- Publication type:
- Article
Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer.
- Published in:
- BJU International, 2021, v. 127, n. 4, p. 435, doi. 10.1111/bju.15227
- By:
- Publication type:
- Article
Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 7321, doi. 10.2147/CMAR.S216605
- By:
- Publication type:
- Article
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. 642, doi. 10.1093/oncolo/oyad058
- By:
- Publication type:
- Article
Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 364, doi. 10.1093/oncolo/oyac244
- By:
- Publication type:
- Article
Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 198, doi. 10.1093/oncolo/oyab046
- By:
- Publication type:
- Article
Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable Chordoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e847, doi. 10.1002/onco.13720
- By:
- Publication type:
- Article
Molecular Profiling of Exceptional Responders to Cancer Therapy.
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. 186, doi. 10.1002/onco.13600
- By:
- Publication type:
- Article
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. 560, doi. 10.1634/theoncologist.2019-0932
- By:
- Publication type:
- Article
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 479, doi. 10.1634/theoncologist.2019-0608
- By:
- Publication type:
- Article
Effect of Talactoferrin Alfa on the Immune System in Adults With Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2013, v. 18, n. 7, p. 821, doi. 10.1634/theoncologist.2013-0199
- By:
- Publication type:
- Article
Neoadjuvant Immunotherapy: An Evolving Paradigm Shift?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Editorial: Local Immunotherapy: A Way to Convert Tumors From "Cold" to "Hot".
- Published in:
- 2017
- By:
- Publication type:
- journal article
Fast Clearance of the SARS-CoV-2 Virus in a Patient Undergoing Vaccine Immunotherapy for Metastatic Chordoma: A Case Report.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.603248
- By:
- Publication type:
- Article
Recurrent Bulbar Paralysis Caused by Botulinum Toxin Type B.
- Published in:
- Clinical Infectious Diseases, 2008, v. 46, n. 8, p. e72, doi. 10.1086/533470
- By:
- Publication type:
- Article